Protocols

New Protocols (0*)

* The protocols may appear repeatedly under different diseases

Updated Protocols (8*)

* The protocols may appear repeatedly under different diseases

Lung Carcinoma, Small Cell

  • Atezolimab 1200 / Carboplatin 5 / Etoposide 100, Small Cell Lung Cancer PID 1341 V1.2 (2024-02-20)
    V1.2: Addition of the corticosteroid for antiemesis under immunotherapy and correction of the sequence of substances according to the study supplement V1.1: Cato test done. Removal of corticosteroid according to Della Corte 2019 / Arbour 2018, replacement of Granisetron by Palonosetron during immunotherapy. V1.0: Cato test done. V0.1: Order according to primary literature, durations according to summary of product characteristics.

Gastric Cancer

Esophageal Cancer

Protocols in Revision

Acute Lymphoblastic Leukaemia

  • Methotrexate 15, Malignant Meningitis, CNS Prophylaxis PID 876 V1.1

Acute Myeloid Leukemia

  • High-dose Cytarabine 3000, Acute Myeloid Leukemia, consolidation, less than 60 years of age, day 1,3,5 PID 516 V1.2

Ewing Sarcoma

  • Irinotecan 20 / Temozolomide 100, Ewing Sarcoma PID 1199 V1.1

Colon Cancer

  • Fluorouracil 2600 / Sodium Folinate 500, Colorectal Carcinoma PID 51 V1.1

Lung Carcinoma, Small Cell

  • EPICO - Epirubicin 40 / Cyclophosphamide 750 / Vincristine 1.5, Small Cell Lung Carcinoma PID 259 V1.1

Gastric Cancer

  • Pembrolizumab 200 / FLOT (Docetaxel 50 / Oxaliplatin 85 / Folinic Acid 200 / Fluorouracil 2600) - PEMB200, Adenocarcinoma Esophagogastric Junction and Stomach, perioperative, cycle 7-17 PID 2235 V1.1
  • Pembrolizumab 200 / FLOT (Docetaxel 50 / Oxaliplatin 85 / Folinic Acid 200 / Fluorouracil 2600), Adenocarcinoma Esophagogastric Junction and Stomach, perioperative, cycle 1,4 PID 2232 V1.1
  • Pembrolizumab 200 / FLOT (Docetaxel 50 / Oxaliplatin 85 / Folinic Acid 200 / Fluorouracil 2600), Adenocarcinoma Esophagogastric Junction and Stomach, perioperative, cycle 2,5 PID 2233 V1.1
  • Pembrolizumab 200 / FLOT (Docetaxel 50 / Oxaliplatin 85 / Folinic Acid 200 / Fluorouracil 2600), Adenocarcinoma Esophagogastric Junction and Stomach, perioperative, cycle 3,6 PID 2234 V1.1

Malignant Meningitis

  • Methotrexate 15, Malignant Meningitis, CNS Prophylaxis PID 876 V1.1
  • Thiotepa 10, Malignant Meningitis PID 867 V1.1

Multiple Myeloma

  • Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 1 PID 41 V1.2
  • Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 2-3 PID 42 V1.2

Esophageal Cancer

  • Pembrolizumab 200 / FLOT (Docetaxel 50 / Oxaliplatin 85 / Folinic Acid 200 / Fluorouracil 2600) - PEMB200, Adenocarcinoma Esophagogastric Junction and Stomach, perioperative, cycle 7-17 PID 2235 V1.1
  • Pembrolizumab 200 / FLOT (Docetaxel 50 / Oxaliplatin 85 / Folinic Acid 200 / Fluorouracil 2600), Adenocarcinoma Esophagogastric Junction and Stomach, perioperative, cycle 1,4 PID 2232 V1.1
  • Pembrolizumab 200 / FLOT (Docetaxel 50 / Oxaliplatin 85 / Folinic Acid 200 / Fluorouracil 2600), Adenocarcinoma Esophagogastric Junction and Stomach, perioperative, cycle 2,5 PID 2233 V1.1
  • Pembrolizumab 200 / FLOT (Docetaxel 50 / Oxaliplatin 85 / Folinic Acid 200 / Fluorouracil 2600), Adenocarcinoma Esophagogastric Junction and Stomach, perioperative, cycle 3,6 PID 2234 V1.1

Soft Tissue Sarcoma

  • VIT (Temozolomide 125 / Vincristine 2 / Irinotecan 50), Soft Tissue Sarcoma, Cycle 1 PID 2255 V1.1
  • VIT (Temozolomide 150 / Vincristine 2 / Irinotecan 50), Soft Tissue Sarcoma, Cycle 2-12 PID 2256 V1.1